Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 24, 2011
Fifty years of "the pill": risk reduction and discovery of benefits beyond contraception, reflections, and forecast
Kristina D Chadwick, Ronald T Burkman, Belen M Tornesi, et al.
Toxicology and Applied Pharmacology
|
August 8, 2021
Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys
Kary E Thompson, Martin Guillot, Michael J Graziano, et al.
Bioanalysis
|
February 16, 2019
A practical workflow for capillary microsampling in nonclinical studies
Linna Wang, Bonnie Wang, Kristina D Chadwick, et al.
Cardiovascular Diabetology
|
September 15, 2017
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Pia S Pollack, Kristina D Chadwick, David M Smith, et al.
The AAPS Journal
|
March 11, 2020
Investigation on the Effect of Capillary Microsampling on Hematologic and Toxicokinetic Evaluation in Regulatory Safety Studies in Mice
Bonnie Wang, Linna Wang, Alicja Batog, et al.
Analytical Chemistry
|
July 9, 2014
Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC-MS/MS coupled with in-source CID
Jiachang Gong, Xiaomei Gu, William E Achanzar, et al.
Diabetes
|
November 14, 2013
Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies
Kristina D Chadwick, Anthony M Fletcher, M Cecilia Parrula, et al.
ACR Open Rheumatology
|
June 26, 2025
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
Fareeda Hosein, Stanislav Ignatenko, Kristina D Chadwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections
Aberra Fura, Ashish Khanna, Viral Vyas, et al.
Toxicologic Pathology
|
February 24, 2018
Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats
Mark Tirmenstein, Evan Janovitz, Thomas Dorr, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 24, 2011
Fifty years of "the pill": risk reduction and discovery of benefits beyond contraception, reflections, and forecast
Kristina D Chadwick, Ronald T Burkman, Belen M Tornesi, et al.
Toxicology and Applied Pharmacology
|
August 8, 2021
Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys
Kary E Thompson, Martin Guillot, Michael J Graziano, et al.
Bioanalysis
|
February 16, 2019
A practical workflow for capillary microsampling in nonclinical studies
Linna Wang, Bonnie Wang, Kristina D Chadwick, et al.
Cardiovascular Diabetology
|
September 15, 2017
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Pia S Pollack, Kristina D Chadwick, David M Smith, et al.
The AAPS Journal
|
March 11, 2020
Investigation on the Effect of Capillary Microsampling on Hematologic and Toxicokinetic Evaluation in Regulatory Safety Studies in Mice
Bonnie Wang, Linna Wang, Alicja Batog, et al.
Analytical Chemistry
|
July 9, 2014
Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC-MS/MS coupled with in-source CID
Jiachang Gong, Xiaomei Gu, William E Achanzar, et al.
Diabetes
|
November 14, 2013
Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies
Kristina D Chadwick, Anthony M Fletcher, M Cecilia Parrula, et al.
ACR Open Rheumatology
|
June 26, 2025
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
Fareeda Hosein, Stanislav Ignatenko, Kristina D Chadwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections
Aberra Fura, Ashish Khanna, Viral Vyas, et al.
Toxicologic Pathology
|
February 24, 2018
Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats
Mark Tirmenstein, Evan Janovitz, Thomas Dorr, et al.
Page
of 2